Michaela Schwarz
Overview
Explore the profile of Michaela Schwarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gross S, Ihlow J, Busack L, Adamiak K, Schrezenmeier J, Jesse J, et al.
Blood Cancer J
. 2024 Sep;
14(1):160.
PMID: 39284846
Therapy-related acute myeloid leukemia (t-AML) often exhibits adverse (genetic) features. There is ongoing discussion on the impact of t-AML on long-term outcome in AML. Therefore, we retrospectively analyzed clinical and...
2.
Boll J, Alashkar F, Aramayo-Singelmann C, Hoferer A, Jarisch A, Kamal H, et al.
Dtsch Med Wochenschr
. 2024 Apr;
149(10):579-586.
PMID: 38657597
Sickle cell disease is a rare, but complex multi-systemic disorder with high need of interdisciplinary and specialized care and new structural requirements. Besides care of those chronically sick patients, transition...
3.
Winkelmann N, Schwarz M, Hildebrandt B, Henke O, Bullinger L, Na I, et al.
EJHaem
. 2022 Sep;
3(3):949-953.
PMID: 36051062
In this analysis, we examined the risk of secondary malignancies for tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia (CML) patients. We also collected data on specific risk factors...
4.
Alashkar F, Aramayo-Singelmann C, Boll J, Hoferer A, Jarisch A, Kamal H, et al.
J Pers Med
. 2022 Jul;
12(7).
PMID: 35887653
Sickle cell disease (SCD) is considered a rare disease in Germany. Due to the increasing prevalence, the acute and chronic morbidities associated with the disease and the sharp increase in...
5.
Ihlow J, Gross S, Busack L, Florcken A, Jesse J, Schwarz M, et al.
Haematologica
. 2021 Nov;
107(8):1773-1785.
PMID: 34758607
In acute myeloid leukemia, there is an ongoing debate on the prognostic value of the early bone marrow assessment in patients receiving intensive therapy. In this retrospective study, we analyzed...
6.
Ihlow J, Gross S, Neuendorff N, Busack L, Herneth A, Singh A, et al.
J Geriatr Oncol
. 2020 Nov;
12(4):540-549.
PMID: 33223482
Objective: In older adults with acute myeloid leukemia (AML), the overall outcome is still dismal and long-term data on survival are scarce, particularly outside of clinical trials. Here, we assess...
7.
Kirschner M, Vieri M, Kricheldorf K, Ventura Ferreira M, Wlodarski M, Schwarz M, et al.
Br J Haematol
. 2020 Aug;
193(3):669-673.
PMID: 32744739
Dyskeratosis Congenita (DKC) is a systemic disorder caused by mutations resulting in impaired telomere maintenance. Clinical features include bone marrow failure and an increased risk of developing hematological malignancies. There...
8.
Mylonas E, Yoshida K, Frick M, Hoyer K, Christen F, Kaeda J, et al.
Nat Commun
. 2020 Jan;
11(1):73.
PMID: 31911629
Cancer development is an evolutionary genomic process with parallels to Darwinian selection. It requires acquisition of multiple somatic mutations that collectively cause a malignant phenotype and continuous clonal evolution is...
9.
Paraiso A, Sousa J, Andrade J, Mangabeira E, Farias Lelis D, de Paula A, et al.
Life Sci
. 2019 Oct;
237:116914.
PMID: 31622606
Aims: The aim of the presente study was to examine the effects of oral gallic acid (GA) administration on the brown adipose tissue of obese mice fed with high-fat diet....
10.
Kirschner M, Maurer A, Wlodarski M, Ventura Ferreira M, Bouillon A, Halfmeyer I, et al.
Leukemia
. 2018 May;
32(8):1762-1767.
PMID: 29749397
Dyskeratosis congenita (DKC) is a paradigmatic telomere disorder characterized by substantial and premature telomere shortening, bone marrow failure, and a dramatically increased risk of developing myelodysplastic syndrome (MDS) or acute...